14 May
Biopharmaceutical R&D Becomes Future Orientation of Pharmaceutical Enterprises
Posted in News and Society on 14.05.12
CRI Report-The driving force for pharmaceutical manufacturing is R&D of new products. According to the 12th Five-Year Plan for Biopharmaceuticals about to be issued, R&D of new drugs will continue being a focus, and the Chinese government will invest over CNY 40 billion in R&D of biopharmaceutical products. At the industrial level, driven by various supporting policies of national industrial upgrading and concentration promotion, China's pharmaceutical industry begins ...
Read more »